Loading...
XSHE
002907
Market cap905mUSD
Oct 09, Last price  
15.44CNY
1D
6.41%
1Q
8.89%
IPO
115.34%
Name

Chongqing Pharscin Pharmaceutical Co Ltd

Chart & performance

D1W1MN
XSHE:002907 chart
P/E
99.06
P/S
7.80
EPS
0.16
Div yield, %
0.59%
Shrs. gr., 5y
0.80%
Rev. gr., 5y
-0.45%
Revenues
827m
+6.75%
347,366,000425,904,327469,319,111551,667,000592,095,363703,415,290842,064,017882,474,476846,141,123846,141,123785,182,813785,182,813691,542,793774,819,866827,144,563
Net income
65m
-15.17%
28,947,00058,754,67973,836,22295,707,732111,987,477137,371,816169,746,083119,187,20291,780,35891,780,36198,400,63598,400,63832,699,15176,730,22765,086,781
CFO
62m
-61.53%
47,338,00020,221,00066,101,00057,733,00081,340,00031,795,00065,916,000113,638,00082,851,00013,045,000219,341,000161,767,00062,239,822
Dividend
Sep 04, 20260.035 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chongqing Pharscin Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the research, development, manufacturing, and distribution of medicines. Its product portfolio encompasses a broad spectrum of pharmaceutical formulations, such as tablets, powders, granules, hard and soft capsules, alongside various injectables including powder, freeze-dried powder, and small volume injections. The company also specializes in active pharmaceutical ingredient (API) synthesis. This diverse range of products targets critical therapeutic areas, including the central nervous system (CNS), digestive health, otolaryngology, oncology, as well as cardiovascular and cerebrovascular conditions. Established in 1996, the company maintains its headquarters in Chongqing, China.

Key people

Xiaoyan Peng
Chief Financial Officer · since 2016
Hongtao You
Chairman of the Board, General Manager · since 2025
Jie Huang
Deputy General Manager · since 2024
Ying Wang
Deputy General Manager · since 2025
Yan Liang
Director · since 2016
Hao Shen
Director · since 2025
Kaiyu Xu
Staff Elected Director · since 2025
Xuedan You
Deputy General Manager, Secretary of the Board, Director · since 2022
Yuanyi You
Director · since 2019
Independent Director · since 2021
Hui Li
Independent Director · since 2021
Independent Director · since 2022
Shaorong Qin
Independent Director · since 2023
Independent Director · since 2016
IPO date
Oct 20, 2017
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
重庆市荣昌区工业园区
万州区, CQ 400000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT